What does RBC Bioscience Corporation do?

RBC Bioscience Corporation (6848.TWO) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 6848.TWO's market cap?

RBC Bioscience Corporation (6848.TWO) has a market capitalization of approximately $335.4 million, as of August 27, 2026, based on the most recent share price and shares outstanding.

Does 6848.TWO pay a dividend?

Yes — RBC Bioscience Corporation (6848.TWO) pays a dividend annually, with a trailing-twelve-month yield of 5.11%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.

6848.TWO

RBC Bioscience Corporation

TWO·Biotechnology · Healthcare

NT$23.50NT$0.55−2.29%

Market capNT$335.42M·Market closed·Aug 27 6:58 AM UTC

Price Chart

NT$23.50−NT$0.55 (−2.29%)today

−46.95%CAGR −12.28%

Select date range

FromTo

Oct 25, 2021Oct 25, 2021 → Aug 27, 2026· 4.8 yrsAug 27, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)5.11%

Annual Dividend (FWD)NT$1.20

Dividend Growth (5Y)—

Dividend Safety—

Payout Ratio73.2%

FCF Payout Ratio40.8%

Most Recent DividendNT$1.20

Ex-Dividend DateJul 9

Payment DateAug 7

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)−7.3%

EPS Growth (3Y)—

EPS Growth (5Y)−27.8%

Next Earnings Date—

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

FinancialsFinancials Tab

RevenueNT$220.60M

Net IncomeNT$21.06M

Net Margin9.5%

Operating Cash FlowNT$41.40M

Capital ExpendituresNT$543.00K

Free Cash FlowNT$41.95M

Return on Equity8.1%

Return on Invested Capital1.2%

Net DebtNT$345.67M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 6848.TWO and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 6848.TWO's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 6848.TWO and 80,000+ other tickers.

About RBC Bioscience Corporation

RBC Bioscience Corporation is a firm dedicated to the research, development, production, and sale of specialized reagents and advanced equipment. These products cater to the life sciences and molecular diagnostic sectors. Its market reach is extensive, covering Europe, the United States, Asia, Taiwan, Africa, and Australia. The company's diverse product line includes reagents tailored for molecular biomedical diagnostics and scientific research, alongside automated instruments for gene and nucleic acid extraction. It also provides a range of nucleic acid extraction kits and associated reagent…

CEO: Mingwei Zhuo
Sector: Healthcare
Industry: Biotechnology
Exchange: TWO
Employees: 50
Website: www.rbcbioscience.com

Peers

Peers Tab

6744.TWO

Feng Chi Biotech Corp.

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 6848.TWO

What does RBC Bioscience Corporation do?: RBC Bioscience Corporation (6848.TWO) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 6848.TWO's market cap?: RBC Bioscience Corporation (6848.TWO) has a market capitalization of approximately $335.4 million, as of August 27, 2026, based on the most recent share price and shares outstanding.
Does 6848.TWO pay a dividend?: Yes — RBC Bioscience Corporation (6848.TWO) pays a dividend annually, with a trailing-twelve-month yield of 5.11%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.